Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments.
Mahmoud S. Alghamri,Brandon L. McClellan,Margaret S. Hartlage,Santiago Haase,Syed M Faisal,Rohit Thalla,Ali Dabaja,Kaushik Banerjee,Stephen Carney,Anzar A. Mujeeb,Michael R. Olin,James J. Moon,Anna Schwendeman,Pedro R. Lowenstein,Maria G. Castro +14 more
Reads0
Chats0
TLDR
Glioblastomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1, as discussed by the authors.Abstract:
Gliomas are one of the most lethal types of cancers accounting for ~80% of all central nervous system (CNS) primary malignancies [1; 2]. Amongst gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies uncovered the genetic signatures and methylation status of gliomas and correlate these with clinical prognosis [2]. The most relevant molecular characteristics for the new glioma classification are IDH mutation, chromosome 1p/19q deletion, histone mutations, and other genetic parameters such as ATRX loss, TP53, and TERT mutations, as well as DNA methylation levels. Similar to other solid tumors, glioma progression is impacted by the complex interactions between the tumor cells and immune cells within the tumor microenvironment. The immune system’s response to cancer can impact the glioma’s survival, proliferation, and invasiveness. Salient characteristics of gliomas include enhanced vascularization, stimulation of a hypoxic tumor microenvironment, increased oxidative stress, and an immune suppressive milieu. These processes promote the neuro-inflammatory tumor microenvironment which can lead to the loss of blood-brain barrier (BBB) integrity. The consequences of a compromised BBB are deleteriously exposing the brain to potentially harmful concentrations of substances from the peripheral circulation, adversely affecting neuronal signaling, and abnormal immune cell infiltration; all of which can lead to disruption of brain homeostasis. In this review, we first describe the unique features of inflammation in CNS tumors. We then discuss the mechanisms of tumor-initiating neuro-inflammatory microenvironment and its impact on tumor invasion and progression. Finally, we also discuss potential pharmacological interventions that can be used to target neuro-inflammation in gliomas.read more
Citations
More filters
Journal ArticleDOI
RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS
Reshma Raghava Kurup,Eimile Oakes,Aidan C. Manning,Priyanka Mukherjee,Pranathi Vadlamani,Heather A. Hundley +5 more
TL;DR: In this article , a global view of ADAR3-bound RNAs in glioblastoma cells and identifies both a role for ADAR-3 in repressing ADAR1-mediated editing and an RNA-binding dependent function of adar3 in regulating MAVS expression.
Journal ArticleDOI
Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches.
TL;DR: In this article, a review of recent advances in imaging methods that have helped to improve the specificity of primary tumor diagnosis versus evaluation of inflamed and necrotic brain lesions is presented.
Journal ArticleDOI
Dopamine, Immunity, and Disease
Breana Channer,Stephanie M. Matt,E. A. Nickoloff-Bybel,Vassiliki Pappa,Yash Agarwal,Jason R Wickman,Peter J. Gaskill +6 more
TL;DR: In this article , a review comprehensively assesses the current knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopamine regulation of immunity.
Journal ArticleDOI
Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen,Marwa M. Nagib,Nelufar Yasmen,Madison N. Sluter,Taylor L Littlejohn,Ying Yu,Jianxiong Jiang +6 more
Journal ArticleDOI
Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
TL;DR: The risk of malignant brain tumors associated with metformin use has rarely been investigated in humans as discussed by the authors, and the authors in this retrospective cohort study investigated such an association in humans.
References
More filters
Journal ArticleDOI
PD-1 blockade enhances the vaccination-induced immune response in glioma.
Joseph Antonios,Horacio Soto,Richard Everson,Joey Orpilla,Diana Moughon,Namjo Shin,Shaina Sedighim,William H. Yong,Gang Li,Timothy F. Cloughesy,Linda M. Liau,Robert M. Prins +11 more
TL;DR: Findings strongly suggest that the PD-1/PD-L1 pathway plays an important role in the adaptive immune resistance of established GBM in response to antitumor active vaccination and provide a rationale for the clinical translation of this combination therapy.
Journal ArticleDOI
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).
Janka Held-Feindt,Kirsten Hattermann,Susanne Sebens Müerköster,Hanna Wedderkopp,Friederike Knerlich-Lukoschus,Hendrik Ungefroren,H. Maximilian Mehdorn,Rolf Mentlein +7 more
TL;DR: Data indicate that the CX3CL1/CX3CR1 system has a crucial tumor-promoting role in human glioblastomas via its impact on glioma-infiltrating immune subsets.
Journal ArticleDOI
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC.
Timothy F. Cloughesy,Joseph Landolfi,Michael A. Vogelbaum,Derek Ostertag,James B. Elder,Stephen Bloomfield,Bob S. Carter,Clark C. Chen,Steven N. Kalkanis,Santosh Kesari,Albert Lai,Ian Lee,Linda M. Liau,Tom Mikkelsen,Phioanh L. Nghiemphu,David Piccioni,William P. Accomando,Oscar Diago,Daniel J. Hogan,Dawn Gammon,Noriyuki Kasahara,Thian Kheoh,Douglas J. Jolly,Harry E. Gruber,Asha Das,Tobias Walbert +25 more
TL;DR: Multiyear durable responses have been observed in rHGG patients treated with Toca 511 + Toca FC in a phase I trial, and the treatment will be further evaluated in a randomized phase III trial.
Journal ArticleDOI
Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis.
David A. Copland,Claudia J. Calder,Ben J. E. Raveney,Lindsay B. Nicholson,Joseph H. Phillips,Holly Cherwinski,Maria C. Jenmalm,Jonathon D. Sedgwick,Andrew D. Dick +8 more
TL;DR: It is demonstrated that promoting CD200R-mediated signaling can successfully prevent full expression of IFNgamma-mediated macrophage activation and protect against tissue damage during autoimmune responses.
Journal ArticleDOI
Astrocytes are necessary for blood-brain barrier maintenance in the adult mouse brain.
Benjamin P. Heithoff,Kijana K. George,Aubrey N. Phares,Ivan A. Zuidhoek,Carmen Muñoz-Ballester,Stefanie Robel +5 more
TL;DR: Astrocytes are necessary to maintain BBB integrity in the adult brain and BBB‐regulating factors secreted by other cell types, such as pericytes, are not sufficient to compensate for astrocyte loss.